Saw palmetto is the most-studied botanical agent for androgenetic alopecia and the only one with published head-to-head data against finasteride. The results deserve a careful reading rather than either enthusiastic endorsement or dismissal — there is real signal here, alongside real methodological limitations.
Mechanism: How Saw Palmetto Acts on DHT
Saw palmetto (Serenoa repens) extract inhibits 5-alpha-reductase (5AR), the enzyme that converts testosterone to dihydrotestosterone (DHT). This is the same mechanism as finasteride, making it a pharmacologically plausible hair loss intervention. Saw palmetto inhibits primarily 5AR type 1 (dominant in skin and liver), while finasteride at 1mg targets type 2 (dominant in scalp follicles) more potently. Some formulations show dual inhibition at higher doses.
Saw palmetto also appears to act as a weak androgen receptor antagonist and has anti-inflammatory properties in vitro. Whether these secondary mechanisms contribute clinically is unknown.
The Randomized Trial Evidence
The most-referenced comparative study is a 2-year trial (Prager et al., 2002) randomizing men to 200 mg saw palmetto extract daily versus 1 mg finasteride. The finding: 38% of the saw palmetto group showed hair count improvement versus 68% in the finasteride group. Saw palmetto was less effective but not ineffective.
| Study | Duration | Saw Palmetto Response | Finasteride Response | Comparison |
|---|---|---|---|---|
| Prager 2002 | 24 months | 38% improved | 68% improved | Fin significantly superior |
| Rossi 2012 (topical) | 24 months | Topical SP showed improvement | Not included | Vs. placebo only |
| Evron 2020 (combination) | 6 months | Combination improved vs. placebo | Not isolated | Combination study |
The Prager 2002 trial had a relatively small sample size (n=26) and used self-assessment of "improvement" without standardized hair count or phototrichogram methodology. Larger, more rigorously controlled trials are needed before saw palmetto can claim comparable evidence strength to finasteride.
Systematic Review and Meta-Analytic Findings
A 2020 systematic review published in the Journal of the American Academy of Dermatology evaluated saw palmetto across all hair loss indications. Across included studies, saw palmetto was consistently better than placebo and consistently worse than finasteride. The reviewers graded evidence as moderate quality, limited by small sample sizes and heterogeneous outcome measures.
Who Might Reasonably Choose Saw Palmetto
The evidence does not support saw palmetto as a replacement for finasteride in men who tolerate that medication. However, several categories of men might reasonably use it as a complement or alternative:
- Men who tried finasteride and experienced persistent side effects and discontinued
- Men in early Norwood stages who prefer to attempt botanical interventions before pharmaceuticals
- Men using finasteride who want to add a complementary agent (though synergy data is limited)
Side Effect Profile
Saw palmetto's published adverse effect rates are lower than finasteride in the available literature, though the trials are underpowered to reliably detect low-frequency side effects. Gastrointestinal upset is the most common complaint. Sexual side effects have been reported in some studies but at rates not significantly different from placebo in most trials. Given its 5AR-inhibiting mechanism, persistent sexual side effects are biologically plausible — though less well-documented than with finasteride.